Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.
about
Cannabis and psychosis: NeurobiologyCannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.Long-term consequences of adolescent cannabinoid exposure in adult psychopathology.Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation.Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult ratsShould burden of disease estimates include cannabis use as a risk factor for psychosis?Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental modelsAdolescent exposure to cannabis as a risk factor for psychiatric disorders.Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophreniaNew insights on endocannabinoid transmission in psychomotor disorders.Lifelong imbalanced LA/ALA intake impairs emotional and cognitive behavior via changes in brain endocannabinoid system.Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system.Neuregulin-1 impairs the long-term depression of hippocampal inhibitory synapses by facilitating the degradation of endocannabinoid 2-AGTHC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia.The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice.Spontaneous object recognition and its relevance to schizophrenia: a review of findings from pharmacological, genetic, lesion and developmental rodent models.Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids.Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia.Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia.Inhibition of cerebral type 1 cannabinoid receptors is associated with impaired auditory mismatch negativity generation in the ketamine model of schizophrenia.Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine.Endocannabinoids and Schizophrenia.
P2860
Q27024404-CA02038A-5E25-4EDA-9871-41F85DFAB6F5Q30403787-02846B9B-2007-4DCB-A745-2B35FEE911DDQ30424669-72ECFF9C-B425-4C99-95C7-A90640E00CC8Q30446489-C90E48E0-8BB9-4B51-B32E-C876F9F716E9Q30473707-81D599AB-5AA2-4AF0-A283-B2EF1A30C0D1Q30475004-D3449BEB-71A6-478A-A1BF-744417F098F7Q33507244-BE23A9D7-E8A1-4F73-B7C9-BC3291695C0BQ33819365-47EB5F09-D292-41D2-A7FA-575C4AC69864Q34098209-3F88E14D-D1C6-4BD5-95E2-0AA621AEEF92Q34201476-96EFC047-7F65-4D85-B295-8FAB3C47B906Q35203644-31405CAF-F69D-41E0-8004-150CDE70AC91Q36074595-81ECEF1C-C1A5-420F-A12C-120E15D6A6A6Q36208674-D2456CEE-7455-401D-9924-4094E9B3ABD1Q36604575-B3B05946-3422-490B-BF82-94FBFDE7797BQ37179736-6EB9C5D1-82D0-4B1C-A716-CF15E1292634Q37597632-991A4FA6-EBD3-4E6A-95E1-16786C6D6F40Q37714575-552445D8-5B78-468D-9370-DA1205AE78C7Q37954123-D2A90627-D7E5-41AF-B327-A446F19D1264Q38026790-84993F84-4A2B-4B32-B3E7-1F9D90CF2E5AQ38697025-1B72E2BD-D1DD-44F5-BCA1-5A92C289C708Q48165414-AFCFFF93-61CD-4B19-8710-F80F1F44022DQ48262695-03E9532E-CED6-4388-B9BB-2A5D555F816CQ48286778-CE9303AD-7120-4591-98FB-CBD999C018E9Q55452539-5E8A26CC-4D46-4EC3-A8E7-2D0AB1873028
P2860
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Involvement of the endocannabi ...... icits modelling schizophrenia.
@en
Involvement of the endocannabi ...... icits modelling schizophrenia.
@nl
type
label
Involvement of the endocannabi ...... icits modelling schizophrenia.
@en
Involvement of the endocannabi ...... icits modelling schizophrenia.
@nl
prefLabel
Involvement of the endocannabi ...... icits modelling schizophrenia.
@en
Involvement of the endocannabi ...... icits modelling schizophrenia.
@nl
P2093
P2860
P1476
Involvement of the endocannabi ...... icits modelling schizophrenia.
@en
P2093
Cinzia Guidali
Daniela Parolaro
Daniela Vigano
Natalia Realini
Stefania Petrosino
P2860
P304
P356
10.1017/S1461145708009371
P577
2008-09-15T00:00:00Z